메뉴 건너뛰기




Volumn 18, Issue 13, 2012, Pages 3524-3531

Novel aspects of mevalonate pathway inhibitors as antitumor agents

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; BROMOHYDRIN PYROPHOSPHATE; CHOLESTEROL; DIMETHYLALLYLTRANSFERASE; DIMETHYLALLYLTRANSFERASE INHIBITOR; FLUINDOSTATIN; GERANYLTRANSFERASE; GLUCOSE REGULATED PROTEIN 78; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; MEVALONIC ACID; MEVINOLIN; PAMIDRONIC ACID; PROTEIN P53; RAS PROTEIN; RHO FACTOR; SIMVASTATIN; TIPIFARNIB; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

EID: 84863317657     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0489     Document Type: Review
Times cited : (196)

References (61)
  • 1
    • 0025120211 scopus 로고
    • Regulation of the mevalonate pathway
    • Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-30.
    • (1990) Nature , vol.343 , pp. 425-430
    • Goldstein, J.L.1    Brown, M.S.2
  • 4
    • 0036729485 scopus 로고    scopus 로고
    • American society of clinical oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma
    • DOI 10.1200/JCO.2002.06.037
    • Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, et al. American Society of Clinical Oncology Bisphosphonates Expert Panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002; 20:3719-36. (Pubitemid 34983232)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.17 , pp. 3719-3736
    • Berenson, J.R.1    Hillner, B.E.2    Kyle, R.A.3    Anderson, K.4    Lipton, A.5    Yee, G.C.6    Biermann, J.S.7
  • 5
    • 34347369084 scopus 로고    scopus 로고
    • Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
    • DOI 10.1038/nrd2221, PII NRD2221
    • Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Posttranslational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 2007;6:541-55. (Pubitemid 47019443)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.7 , pp. 541-555
    • Konstantinopoulos, P.A.1    Karamouzis, M.V.2    Papavassiliou, A.G.3
  • 6
    • 33646354412 scopus 로고    scopus 로고
    • Statin therapy and autoimmune disease: From protein prenylation to immunomodulation
    • Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006;6:358-70.
    • (2006) Nat Rev Immunol , vol.6 , pp. 358-370
    • Greenwood, J.1    Steinman, L.2    Zamvil, S.S.3
  • 7
    • 77955758944 scopus 로고    scopus 로고
    • Novel bone-targeted strategies in oncology
    • Vallet S, Smith MR, Raje N. Novel bone-targeted strategies in oncology. Clin Cancer Res 2010;16:4084-93.
    • (2010) Clin Cancer Res , vol.16 , pp. 4084-4093
    • Vallet, S.1    Smith, M.R.2    Raje, N.3
  • 8
    • 0036239832 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
    • DOI 10.1038/sj/leu/2402476
    • Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19. (Pubitemid 34460459)
    • (2002) Leukemia , vol.16 , Issue.4 , pp. 508-519
    • Wong, W.W.-L.1    Dimitroulakos, J.2    Minden, M.D.3    Penn, L.Z.4
  • 11
    • 77954756757 scopus 로고    scopus 로고
    • Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
    • Clendening JW, Pandyra A, Li Z, Boutros PC, Martirosyan A, Lehner R, et al. Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. Blood 2010;115:4787-97.
    • (2010) Blood , vol.115 , pp. 4787-4797
    • Clendening, J.W.1    Pandyra, A.2    Li, Z.3    Boutros, P.C.4    Martirosyan, A.5    Lehner, R.6
  • 14
    • 77955881211 scopus 로고    scopus 로고
    • Can oral bisphosphonates really reduce the risk of breast cancer in healthy women?
    • Gnant M. Can oral bisphosphonates really reduce the risk of breast cancer in healthy women? J Clin Oncol 2010;28:3548-51.
    • (2010) J Clin Oncol , vol.28 , pp. 3548-3551
    • Gnant, M.1
  • 15
    • 33644666787 scopus 로고    scopus 로고
    • Bisphosphonates for treatment and prevention of bone metastases
    • DOI 10.1200/JCO.2005.02.9579
    • Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 2005;23:8219-24. (Pubitemid 46211558)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.32 , pp. 8219-8224
    • Michaelson, M.D.1    Smith, M.R.2
  • 16
    • 30844467746 scopus 로고    scopus 로고
    • Lipid posttranslational modifications. Farnesyl transferase inhibitors
    • Basso AD, Kirschmeier P, Bishop WR. Lipid posttranslational modifications. Farnesyl transferase inhibitors. J Lipid Res 2006;47: 15-31.
    • (2006) J Lipid Res , vol.47 , pp. 15-31
    • Basso, A.D.1    Kirschmeier, P.2    Bishop, W.R.3
  • 18
    • 16544382706 scopus 로고    scopus 로고
    • Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies
    • Zimmerman TM, Harlin H, Odenike OM, Berk S, Sprague E, Karrison T, et al. Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies. J Clin Oncol 2004;22:4816-22.
    • (2004) J Clin Oncol , vol.22 , pp. 4816-4822
    • Zimmerman, T.M.1    Harlin, H.2    Odenike, O.M.3    Berk, S.4    Sprague, E.5    Karrison, T.6
  • 20
    • 18744363084 scopus 로고    scopus 로고
    • Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: Preclinical and clinical implications
    • DOI 10.2174/1389450053765833
    • Caraglia M, Budillon A, Tagliaferri P, Marra M, Abbruzzese A, Caponigro F. Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr Drug Targets 2005;6:301-23. (Pubitemid 40667797)
    • (2005) Current Drug Targets , vol.6 , Issue.3 , pp. 301-323
    • Caraglia, M.1    Budillon, A.2    Tagliaferri, P.3    Marra, M.4    Abbruzzese, A.5    Caponigro, F.6
  • 21
    • 0035364973 scopus 로고    scopus 로고
    • Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells
    • DOI 10.1054/bjoc.2001.1820
    • Di Paolo A, Danesi R, Caputo S, Macchia M, Lastella M, Boggi U, et al. Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells. Br J Cancer 2001;84:1535-43. (Pubitemid 32579347)
    • (2001) British Journal of Cancer , vol.84 , Issue.11 , pp. 1535-1543
    • Di, P.A.1    Danesi, R.2    Caputo, S.3    Macchia, M.4    Lastella, M.5    Boggi, U.6    Mosca, F.7    Marchetti, A.8    Del, T.M.9
  • 24
    • 22244446505 scopus 로고    scopus 로고
    • The mammalian unfolded protein response
    • DOI 10.1146/annurev.biochem.73.011303.074134
    • Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-89. (Pubitemid 40995523)
    • (2005) Annual Review of Biochemistry , vol.74 , pp. 739-789
    • Schroder, M.1    Kaufman, R.J.2
  • 25
    • 51749116326 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression
    • Chen JC, Wu ML, Huang KC, Lin WW. HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression. Cardiovasc Res 2008;80:138-50.
    • (2008) Cardiovasc Res , vol.80 , pp. 138-150
    • Chen, J.C.1    Wu, M.L.2    Huang, K.C.3    Lin, W.W.4
  • 26
    • 57049117856 scopus 로고    scopus 로고
    • Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities
    • Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008;7:1013-30.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 1013-1030
    • Kim, I.1    Xu, W.2    Reed, J.C.3
  • 27
    • 37649005234 scopus 로고    scopus 로고
    • Autophagy in the pathogenesis of disease
    • Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42.
    • (2008) Cell , vol.132 , pp. 27-42
    • Levine, B.1    Kroemer, G.2
  • 29
    • 43249109174 scopus 로고    scopus 로고
    • Endoplasmic reticulum stress responses
    • Schröder M. Endoplasmic reticulum stress responses. Cell Mol Life Sci 2008;65:862-94.
    • (2008) Cell Mol Life Sci , vol.65 , pp. 862-894
    • Schröder, M.1
  • 30
    • 79951642032 scopus 로고    scopus 로고
    • Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
    • Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-30.
    • (2011) Nat Immunol , vol.12 , pp. 222-230
    • Nakahira, K.1    Haspel, J.A.2    Rathinam, V.A.3    Lee, S.J.4    Dolinay, T.5    Lam, H.C.6
  • 31
    • 84857195479 scopus 로고    scopus 로고
    • Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction
    • Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012;13:255-63.
    • (2012) Nat Immunol , vol.13 , pp. 255-263
    • Shi, C.S.1    Shenderov, K.2    Huang, N.N.3    Kabat, J.4    Abu-Asab, M.5    Fitzgerald, K.A.6
  • 33
    • 67549139908 scopus 로고    scopus 로고
    • Vesicular trafficking and autophagosome formation
    • Longatti A, Tooze SA. Vesicular trafficking and autophagosome formation. Cell Death Differ 2009;16:956-65.
    • (2009) Cell Death Differ , vol.16 , pp. 956-965
    • Longatti, A.1    Tooze, S.A.2
  • 34
    • 73349108071 scopus 로고    scopus 로고
    • CD56 +human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses
    • Gruenbacher G, Gander H, Rahm A, Nussbaumer W, Romani N, Thurnher M. CD56 +human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. Blood 2009;114:4422-31.
    • (2009) Blood , vol.114 , pp. 4422-4431
    • Gruenbacher, G.1    Gander, H.2    Rahm, A.3    Nussbaumer, W.4    Romani, N.5    Thurnher, M.6
  • 35
    • 34848837386 scopus 로고    scopus 로고
    • Taking dendritic cells into medicine
    • DOI 10.1038/nature06175, PII NATURE06175
    • Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419-26. (Pubitemid 47509552)
    • (2007) Nature , vol.449 , Issue.7161 , pp. 419-426
    • Steinman, R.M.1    Banchereau, J.2
  • 36
    • 78649964343 scopus 로고    scopus 로고
    • IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells
    • Gruenbacher G, Gander H, Nussbaumer O, Nussbaumer W, Rahm A, Thurnher M. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells. Cancer Res 2010;70:9611-20.
    • (2010) Cancer Res , vol.70 , pp. 9611-9620
    • Gruenbacher, G.1    Gander, H.2    Nussbaumer, O.3    Nussbaumer, W.4    Rahm, A.5    Thurnher, M.6
  • 37
    • 22944486712 scopus 로고    scopus 로고
    • Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity
    • DOI 10.1084/jem.20050810
    • Münz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 2005;202:203-7. (Pubitemid 41043815)
    • (2005) Journal of Experimental Medicine , vol.202 , Issue.2 , pp. 203-207
    • Munz, C.1    Steinman, R.M.2    Fujii, S.-I.3
  • 38
    • 77956593114 scopus 로고    scopus 로고
    • Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
    • Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 2010;116: 1726-33.
    • (2010) Blood , vol.116 , pp. 1726-1733
    • Maniar, A.1    Zhang, X.2    Lin, W.3    Gastman, B.R.4    Pauza, C.D.5    Strome, S.E.6
  • 39
    • 0033522147 scopus 로고    scopus 로고
    • Gamma/delta T-cell stimulation by pamidronate
    • Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999;340:737-8.
    • (1999) N Engl J Med , vol.340 , pp. 737-738
    • Kunzmann, V.1    Bauer, E.2    Wilhelm, M.3
  • 40
    • 33846804360 scopus 로고    scopus 로고
    • Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: Discriminating friend from foe through the recognition of prenyl pyrophosphate antigens
    • DOI 10.1111/j.1600-065X.2006.00479.x
    • Morita CT, Jin C, Sarikonda G, Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007;215: 59-76. (Pubitemid 46212230)
    • (2007) Immunological Reviews , vol.215 , Issue.1 , pp. 59-76
    • Morita, C.T.1    Jin, C.2    Sarikonda, G.3    Wang, H.4
  • 41
    • 33846454363 scopus 로고    scopus 로고
    • Perspectives of gammadelta T cells in tumor immunology
    • DOI 10.1158/0008-5472.CAN-06-3069
    • Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Res 2007;67:5-8. (Pubitemid 46142752)
    • (2007) Cancer Research , vol.67 , Issue.1 , pp. 5-8
    • Kabelitz, D.1    Wesch, D.2    He, W.3
  • 42
    • 37049006066 scopus 로고    scopus 로고
    • Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma
    • DOI 10.1158/0008-5472.CAN-07-1882
    • Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 2007;67:11438-46. (Pubitemid 350248572)
    • (2007) Cancer Research , vol.67 , Issue.23 , pp. 11438-11446
    • Melani, C.1    Sangaletti, S.2    Barazzetta, F.M.3    Werb, Z.4    Colombo, M.P.5
  • 43
    • 78650051896 scopus 로고    scopus 로고
    • Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
    • Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 2010;14:2803-15.
    • (2010) J Cell Mol Med , vol.14 , pp. 2803-2815
    • Coscia, M.1    Quaglino, E.2    Iezzi, M.3    Curcio, C.4    Pantaleoni, F.5    Riganti, C.6
  • 45
    • 33748804427 scopus 로고    scopus 로고
    • The effect of zoledronic acid on the function and differentiation of myeloid cells
    • Wolf AM, Rumpold H, Tilg H, Gastl G, Gunsilius E, Wolf D. The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica 2006;91:1165-71. (Pubitemid 44408425)
    • (2006) Haematologica , vol.91 , Issue.9 , pp. 1165-1171
    • Wolf, A.M.1    Rumpold, H.2    Tilg, H.3    Gastl, G.4    Gunsilius, E.5    Wolf, D.6
  • 46
    • 33947383077 scopus 로고    scopus 로고
    • Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells
    • DOI 10.1038/sj.leu.2404556, PII 2404556
    • Bringmann A, Schmidt SM, Weck MM, Brauer KM, von Schwarzenberg K, Werth D, et al. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia 2007;21:732-8. (Pubitemid 46444557)
    • (2007) Leukemia , vol.21 , Issue.4 , pp. 732-738
    • Bringmann, A.1    Schmidt, S.M.2    Weck, M.M.3    Brauer, K.M.4    Von, S.K.5    Werth, D.6    Grunebach, F.7    Brossart, P.8
  • 47
    • 80052674947 scopus 로고    scopus 로고
    • DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gd T lymphocytes
    • Nussbaumer O, Gruenbacher G, Gander H, Thurnher M. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gd T lymphocytes. Blood 2011; 118:2743-51.
    • (2011) Blood , vol.118 , pp. 2743-2751
    • Nussbaumer, O.1    Gruenbacher, G.2    Gander, H.3    Thurnher, M.4
  • 48
    • 78650961487 scopus 로고    scopus 로고
    • Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro
    • Ke PY, Chen SS. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest 2011;121:37-56.
    • (2011) J Clin Invest , vol.121 , pp. 37-56
    • Ke, P.Y.1    Chen, S.S.2
  • 49
    • 77953806728 scopus 로고    scopus 로고
    • The inhibition of mevalonate pathway induces upregulation of NALP3 expression: New insight in the pathogenesis of mevalonate kinase deficiency
    • Pontillo A, Paoluzzi E, Crovella S. The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. Eur J Hum Genet 2010;18:844-7.
    • (2010) Eur J Hum Genet , vol.18 , pp. 844-847
    • Pontillo, A.1    Paoluzzi, E.2    Crovella, S.3
  • 50
    • 62649139025 scopus 로고    scopus 로고
    • Immunological and inflammatory functions of the interleukin- 1 family
    • Dinarello CA. Immunological and inflammatory functions of the interleukin- 1 family. Annu Rev Immunol 2009;27:519-50.
    • (2009) Annu Rev Immunol , vol.27 , pp. 519-550
    • Dinarello, C.A.1
  • 51
    • 0034283671 scopus 로고    scopus 로고
    • Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: Involvement of an inhibitory G protein
    • Sadeghi MM, Collinge M, Pardi R, Bender JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein. J Immunol 2000;165: 2712-8. (Pubitemid 30660721)
    • (2000) Journal of Immunology , vol.165 , Issue.5 , pp. 2712-2718
    • Sadeghi, M.M.1    Collinge, M.2    Pardi, R.3    Bender, J.R.4
  • 52
    • 0043166922 scopus 로고    scopus 로고
    • Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production
    • DOI 10.1016/S0008-8749(03)00148-5
    • Sun D, Fernandes G. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol 2003;223:52-62. (Pubitemid 36945549)
    • (2003) Cellular Immunology , vol.223 , Issue.1 , pp. 52-62
    • Sun, D.1    Fernandes, G.2
  • 53
    • 0042930877 scopus 로고    scopus 로고
    • Inhibition of Rho family gtpases results in increased TNFalpha production after lipopolysaccharide exposure
    • Monick MM, Powers LS, Butler NS, Hunninghake GW. Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure. J Immunol 2003;171:2625-30. (Pubitemid 37025575)
    • (2003) Journal of Immunology , vol.171 , Issue.5 , pp. 2625-2630
    • Monick, M.M.1    Powers, L.S.2    Butler, N.S.3    Hunninghake, G.W.4
  • 54
    • 33646016282 scopus 로고    scopus 로고
    • Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes
    • Coward WR, Marei A, Yang A, Vasa-Nicotera MM, Chow SC. Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. J Immunol 2006;176:5284-92.
    • (2006) J Immunol , vol.176 , pp. 5284-5292
    • Coward, W.R.1    Marei, A.2    Yang, A.3    Vasa-Nicotera, M.M.4    Chow, S.C.5
  • 55
    • 0034660687 scopus 로고    scopus 로고
    • Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
    • Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:384-92. (Pubitemid 30463353)
    • (2000) Blood , vol.96 , Issue.2 , pp. 384-392
    • Kunzmann, V.1    Bauer, E.2    Feurle, J.3    Weissinger, F.4    Tony, H.-P.5    Wilhelm, M.6
  • 56
    • 0037968274 scopus 로고    scopus 로고
    • Gammadelta T cells for immune therapy of patients with lymphoid malignancies
    • DOI 10.1182/blood-2002-12-3665
    • Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, et al. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 2003;102:200-6. (Pubitemid 36759655)
    • (2003) Blood , vol.102 , Issue.1 , pp. 200-206
    • Wilhelm, M.1    Kunzmann, V.2    Eckstein, S.3    Reimer, P.4    Weissinger, F.5    Ruediger, T.6    Tony, H.-P.7
  • 59
    • 77954652637 scopus 로고    scopus 로고
    • In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
    • Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, et al. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 2010;161:290-7.
    • (2010) Clin Exp Immunol , vol.161 , pp. 290-297
    • Meraviglia, S.1    Eberl, M.2    Vermijlen, D.3    Todaro, M.4    Buccheri, S.5    Cicero, G.6
  • 60
    • 50649102839 scopus 로고    scopus 로고
    • Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
    • Bennouna J, Bompas E, Neidhardt EM, Rolland F, Philip I, Galéa C, et al. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 2008;57:1599-609.
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 1599-1609
    • Bennouna, J.1    Bompas, E.2    Neidhardt, E.M.3    Rolland, F.4    Philip, I.5    Galéa, C.6
  • 61
    • 77951296062 scopus 로고    scopus 로고
    • A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells
    • Nakajima J, Murakawa T, Fukami T, Goto S, Kaneko T, Yoshida Y, et al. A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells. Eur J Cardiothorac Surg 2010;37:1191-7.
    • (2010) Eur J Cardiothorac Surg , vol.37 , pp. 1191-1197
    • Nakajima, J.1    Murakawa, T.2    Fukami, T.3    Goto, S.4    Kaneko, T.5    Yoshida, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.